AAAAAA

   
Results: 1-10 |
Results: 10
THE PHARMACOLOGY OF NEUROPEPTIDE-Y (NPY) RECEPTOR-MEDIATED FEEDING INRATS CHARACTERIZES BETTER Y5 THAN Y1, BUT NOT Y2 OR Y4 SUBTYPES
Authors: WYSS P STRICKERKRONGRAD A BRUNNER L MILLER J CROSSTHWAITE A WHITEBREAD S CRISCIONE L
Citation: P. Wyss et al., THE PHARMACOLOGY OF NEUROPEPTIDE-Y (NPY) RECEPTOR-MEDIATED FEEDING INRATS CHARACTERIZES BETTER Y5 THAN Y1, BUT NOT Y2 OR Y4 SUBTYPES, Regulatory peptides, 75-6, 1998, pp. 363-371
CYTOKINES IN MURINE LYME CARDITIS - TH1 CYTOKINE EXPRESSION FOLLOWS EXPRESSION OF PROINFLAMMATORY CYTOKINES IN A SUSCEPTIBLE MOUSE STRAIN
Authors: DOYLE MK TELFORD SR CRISCIONE L LIN SR SPIELMAN A GRAVALLESE EM
Citation: Mk. Doyle et al., CYTOKINES IN MURINE LYME CARDITIS - TH1 CYTOKINE EXPRESSION FOLLOWS EXPRESSION OF PROINFLAMMATORY CYTOKINES IN A SUSCEPTIBLE MOUSE STRAIN, The Journal of infectious diseases, 177(1), 1998, pp. 242-246
INHIBITION OF FOOD-INTAKE BY NEUROPEPTIDE-Y Y5 RECEPTOR ANTISENSE OLIGODEOXYNUCLEOTIDES
Authors: SCHAFFHAUSER AO STRICKERKRONGRAD A BRUNNER L CUMIN F GERALD C WHITEBREAD S CRISCIONE L HOFBAUER KG
Citation: Ao. Schaffhauser et al., INHIBITION OF FOOD-INTAKE BY NEUROPEPTIDE-Y Y5 RECEPTOR ANTISENSE OLIGODEOXYNUCLEOTIDES, Diabetes, 46(11), 1997, pp. 1792-1798
CYTOKINES IN MURINE LYME CARDITIS - TH1 CYTOKINE EXPRESSION FOLLOWS EXPRESSION OF PRO-INFLAMMATORY CYTOKINES IN A SUSCEPTIBLE MOUSE
Authors: DOYLE MK TELFORD SR CRISCIONE L LIN SR SPIELMAN A GRAVALLESE EM
Citation: Mk. Doyle et al., CYTOKINES IN MURINE LYME CARDITIS - TH1 CYTOKINE EXPRESSION FOLLOWS EXPRESSION OF PRO-INFLAMMATORY CYTOKINES IN A SUSCEPTIBLE MOUSE, Arthritis and rheumatism, 40(9), 1997, pp. 43-43
A RECEPTOR SUBTYPE INVOLVED IN NEUROPEPTIDE-Y-INDUCED FOOD-INTAKE
Authors: GERALD C WALKER MW CRISCIONE L GUSTAFSON EL BATZLHARTMANN C SMITH KE VAYSSE P DURKIN MM LAZ TM LINEMEYER DL SCHAFFHAUSER AO WHITEBREAD S HOFBAUER KG TABER RI BRANCHEK TA WEINSHANK RL
Citation: C. Gerald et al., A RECEPTOR SUBTYPE INVOLVED IN NEUROPEPTIDE-Y-INDUCED FOOD-INTAKE, Nature, 382(6587), 1996, pp. 168-171
MECHANISM OF INTERACTION BETWEEN NEUROPEPTIDE-Y AND ANGIOTENSIN-II INTHE RABBIT FEMORAL-ARTERY
Authors: CRESSIER F CRISCIONE L HOFBAUER KG
Citation: F. Cressier et al., MECHANISM OF INTERACTION BETWEEN NEUROPEPTIDE-Y AND ANGIOTENSIN-II INTHE RABBIT FEMORAL-ARTERY, European journal of pharmacology, 272(1), 1995, pp. 57-65
VALSARTAN, A POTENT, ORALLY-ACTIVE ANGIOTENSIN-II ANTAGONIST DEVELOPED FROM THE STRUCTURALLY NEW AMINO-ACID SERIES
Authors: BUHLMAYER P FURET P CRISCIONE L DEGASPARO M WHITEBREAD S SCHMIDLIN T LATTMANN R WOOD J
Citation: P. Buhlmayer et al., VALSARTAN, A POTENT, ORALLY-ACTIVE ANGIOTENSIN-II ANTAGONIST DEVELOPED FROM THE STRUCTURALLY NEW AMINO-ACID SERIES, Bioorganic & medicinal chemistry letters, 4(1), 1994, pp. 29-34
ANGIOTENSIN BLOCKADE OR CALCIUM-ANTAGONISTS IMPROVE ENDOTHELIAL DYSFUNCTION IN HYPERTENSION - STUDIES IN PERFUSED MESENTERIC RESISTANCE ARTERIES
Authors: DOHI Y CRISCIONE L PFEIFFER K LUSCHER TF
Citation: Y. Dohi et al., ANGIOTENSIN BLOCKADE OR CALCIUM-ANTAGONISTS IMPROVE ENDOTHELIAL DYSFUNCTION IN HYPERTENSION - STUDIES IN PERFUSED MESENTERIC RESISTANCE ARTERIES, Journal of cardiovascular pharmacology, 24(3), 1994, pp. 372-379
ANTIHYPERTENSIVE THERAPY AUGMENTS ENDOTHELIUM-DEPENDENT RELAXATIONS IN CORONARY-ARTERIES OF SPONTANEOUSLY HYPERTENSIVE RATS
Authors: TSCHUDI MR CRISCIONE L NOVOSEL D PFEIFFER K LUSCHER TF
Citation: Mr. Tschudi et al., ANTIHYPERTENSIVE THERAPY AUGMENTS ENDOTHELIUM-DEPENDENT RELAXATIONS IN CORONARY-ARTERIES OF SPONTANEOUSLY HYPERTENSIVE RATS, Circulation, 89(5), 1994, pp. 2212-2218
PHARMACOLOGICAL PROFILE OF VALSARTAN - A POTENT, ORALLY-ACTIVE, NONPEPTIDE ANTAGONIST OF THE ANGIOTENSIN-II AT1-RECEPTOR SUBTYPE
Authors: CRISCIONE L DEGASPARO M BUHLMAYER P WHITEBREAD S RAMJOUE HPR WOOD J
Citation: L. Criscione et al., PHARMACOLOGICAL PROFILE OF VALSARTAN - A POTENT, ORALLY-ACTIVE, NONPEPTIDE ANTAGONIST OF THE ANGIOTENSIN-II AT1-RECEPTOR SUBTYPE, British Journal of Pharmacology, 110(2), 1993, pp. 761-771
Risultati: 1-10 |